Application‑level Medical Desktop Electromagnetic Focusing Shock Wave Therapy Device segmentation reveals four dominant end‑use clusters: Urology, Orthopedics, Physical Rehabilitation, and Cosmetics. Urology, driven by chronic prostatitis and kidney stone fragmentation, commands the largest share (≈35 %), reflecting both higher procedure volumes and reimbursement support in major health systems. Orthopedics, encompassing fracture non‑union, plantar fasciitis, and tendinopathy, follows with about 30 % of market value, benefitting from expanding evidence of accelerated bone healing. Physical Rehabilitation, targeting muscle spasm relief and soft‑tissue regeneration, contributes roughly 20 %, propelled by outpatient therapy centres adopting non‑invasive protocols. Cosmetic applications—skin tightening, cellulite reduction, and scar remodeling—represent an emerging niche, accounting for 15 % of sales, yet exhibit the highest compound annual growth rate as aesthetic demand rises. These percentages collectively define the market’s revenue distribution and guide strategic allocation of R&D and marketing resources across the device lifecycle.